EGRX Historical PE Ratio image   This EGRX PE ratio history page last updated 11/8/2022
EGRX Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/7/2022
39.731.124.488.9
Q2 2022
8/9/2022
36.861.566.245.9
Q1 2022
5/9/2022
42.954.0416.162.7
Q4 2021
3/7/2022
47.750.853.4014.0
Q3 2021
11/9/2021
51.400.562.2422.9
Q2 2021
8/9/2021
47.840.933.7212.9
Q1 2021
5/10/2021
38.470.240.9640.1
Q4 2020
3/2/2021
40.400.963.8410.5
Q3 2020
11/2/2020
49.221.174.6810.5
Q2 2020
8/10/2020
43.260.572.2819.0
Q1 2020
5/11/2020
54.570.843.3616.2
Q4 2019
3/2/2020
41.860.481.9221.8
Q3 2019
11/12/2019
58.340.261.0456.1
Q2 2019
8/8/2019
56.930.843.3616.9
Q1 2019
5/7/2019
56.951.014.0414.1
Q4 2018
2/28/2019
50.071.204.8010.4
Q3 2018
11/1/2018
52.231.184.7211.1
Q2 2018
8/7/2018
77.400.953.8020.4
Q1 2018
5/10/2018
62.380.532.1229.4
Q4 2017
2/26/2018
60.921.004.0015.2
Q3 2017
11/8/2017
57.581.224.8811.8
Q2 2017
8/9/2017
49.150.491.9625.1
Q1 2017
5/8/2017
86.341.425.6815.2
Q4 2016
3/1/2017
76.242.6910.767.1
Q3 2016
11/9/2016
81.730.732.9228.0
Q2 2016
8/9/2016
55.430.803.2017.3
Q1 2016
5/9/2016
40.09-0.06-0.24NA
Q4 2015
2/25/2016
66.300.070.28236.8
Q3 2015
11/11/2015
72.39-0.65-2.60NA
Q2 2015
8/11/2015
79.22-0.53-2.12NA
Q1 2015
5/12/2015
59.541.315.2411.4
Q4 2014
12/17/2014
12.98-0.91-3.64NA
Q3 2014
8/11/2014
10.99-0.21-0.84NA
Q2 2014
5/14/2014
9.76-0.36-1.44NA
EGRX PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/7/2022
39.731.127.575.2
Q2 2022
8/9/2022
36.861.567.015.3
Q1 2022
5/9/2022
42.954.046.386.7
Q4 2021
3/7/2022
47.750.852.5818.5
Q3 2021
11/9/2021
51.400.562.6919.1
Q2 2021
8/9/2021
47.840.933.3014.5
Q1 2021
5/10/2021
38.470.242.9413.1
Q4 2020
3/2/2021
40.400.963.5411.4
Q3 2020
11/2/2020
49.221.173.0616.1
Q2 2020
8/10/2020
43.260.572.1520.1
Q1 2020
5/11/2020
54.570.842.4222.5
Q4 2019
3/2/2020
41.860.482.5916.2
Q3 2019
11/12/2019
58.340.263.3117.6
Q2 2019
8/8/2019
56.930.844.2313.5
Q1 2019
5/7/2019
56.951.014.3413.1
Q4 2018
2/28/2019
50.071.203.8613.0
Q3 2018
11/1/2018
52.231.183.6614.3
Q2 2018
8/7/2018
77.400.953.7020.9
Q1 2018
5/10/2018
62.380.533.2419.3
Q4 2017
2/26/2018
60.921.004.1314.8
Q3 2017
11/8/2017
57.581.225.829.9
Q2 2017
8/9/2017
49.150.495.339.2
Q1 2017
5/8/2017
86.341.425.6415.3
Q4 2016
3/1/2017
76.242.694.1618.3
Q3 2016
11/9/2016
81.730.731.5453.1
Q2 2016
8/9/2016
55.430.800.16346.4
Q1 2016
5/9/2016
40.09-0.06-1.17NA
Q4 2015
2/25/2016
66.300.070.20331.5
Q3 2015
11/11/2015
72.39-0.65-0.78NA
Q2 2015
8/11/2015
79.22-0.53-0.34NA
Q1 2015
5/12/2015
59.541.31-0.17NA
Q4 2014
12/17/2014
12.98-0.91NANA
Q3 2014
8/11/2014
10.99-0.21NANA
Q2 2014
5/14/2014
9.76-0.36NANA
Quotes delayed 20 minutes

Email EnvelopeFree EGRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Eagle Pharmaceuticals (EGRX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

EHC PE Ratio History
EIGR PE Ratio History
EKSO PE Ratio History
ELAN PE Ratio History
ELDN PE Ratio History
ELEV PE Ratio History
ELOX PE Ratio History
ELYM PE Ratio History
ENDP PE Ratio History
ENOB PE Ratio History
How should the EGRX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Eagle Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this EGRX Historical PE Ratio page.

What is the average historical PE for EGRX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The EGRX historical PE ratio using the annualized quarterly earnings method works out to 25.4.

What is the average historical PE for EGRX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The EGRX historical PE ratio using the TTM earnings method works out to 40.0.

What is the average historical PE for EGRX based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The EGRX historical PE ratio using the annualized median TTM earnings method works out to 5.36.

On this page we presented the EGRX Historical PE Ratio information for Eagle Pharmaceuticals' stock. The average EGRX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 25.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average EGRX historical PE based on this TTM earnings result method is 40.0. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this EGRX historical PE result, against the recent PE: when this page was posted on 11/7/2022, the most recent closing price for EGRX had been 39.73, and the most recent quarterly earnings result, annualized, was 4.48. Meanwhile, the most recent TTM earnings summed to 7.57. From these numbers, we calculate the recent EGRX PE on 11/7/2022 based on annualized quarterly EPS was 8.9. Based on EGRX's history, that recent PE is low relative to the historical average, with the recent PE 65.0% lower than the historical average PE across our data set for Eagle Pharmaceuticals. Looking at the recent EGRX PE on 11/7/2022 based on TTM EPS, we calculate the ratio at 5.2. Based on EGRX's history, that recent PE is low relative to the historical average, with the recent PE 87.0% lower than the average PE across our Eagle Pharmaceuticals data set with TTM EPS used in the calculation at each period.

Another interesting EGRX historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for EGRX, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for EGRX, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.85, 1.12, 1.56, and 4.04. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 1.12 and 1.56 — which gives us the median of 1.34. Basically the way to think about this 1.34 number is this: for the trailing four earnings reports, 1.34 marks the "middle ground" number where EGRX has reported a value higher than 1.34 half the time, and has reported a value lower than 1.34 half the time. Annualizing that median value then gets us to 5.36/share, which we use as the denominator in our next PE calculation. With 39.73 as the numerator (as of 11/7/2022), the calculation is then 39.73 / 5.36 = 7.4 as the EGRX PE ratio as of 11/7/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on EGRX or any other given stock, valuation analysis for EGRX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Eagle Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for EGRX. Thanks for visiting, and the next time you need to research EGRX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of VIOT, QQMG shares outstanding history, Funds Holding AGRI.

 

EGRX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.